MOH241220P410000
- 70.38
- 0.000.00%
Molina Healthcare Newsroom
Jefferies Maintains Molina Healthcare(MOH.US) With Hold Rating, Cuts Target Price to $312
Wells Fargo Maintains Molina Healthcare(MOH.US) With Hold Rating, Cuts Target Price to $340
Wells Fargo Cuts Price Target on Molina Healthcare to $340 From $362, Maintains Equalweight Rating
Molina Healthcare (MOH) Receives a Hold From Wells Fargo
Jefferies Adjusts Price Target on Molina Healthcare to $348 From $341, Maintains Hold Rating
Truist Financial Maintains Molina Healthcare(MOH.US) With Buy Rating
TD Cowen Maintains Molina Healthcare(MOH.US) With Buy Rating, Maintains Target Price $378
A Quick Look at Today's Ratings for Molina Healthcare(MOH.US), With a Forecast Between $362 to $372
Molina Healthcare (MOH) Receives a Buy From TD Cowen
Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL), Molina Healthcare (MOH) and AnaptysBio (ANAB)
Molina Healthcare: Hold Rating Amid Growth Challenges and Legislative Risks
Barclays Maintains Molina Healthcare(MOH.US) With Hold Rating, Maintains Target Price $372
Analysts Conflicted on These Healthcare Names: Molina Healthcare (MOH), Avidity Biosciences (RNA) and MoonLake Immunotherapeutics (MLTX)
Wells Fargo Maintains Molina Healthcare(MOH.US) With Hold Rating, Raises Target Price to $362
Wells Fargo Remains a Hold on Molina Healthcare (MOH)
Jefferies Maintains Molina Healthcare(MOH.US) With Hold Rating, Raises Target Price to $341
Molina Health Is Maintained at Equal-Weight by Barclays
Molina Healthcare Analyst Ratings
Barclays Maintains Equal-Weight on Molina Healthcare, Raises Price Target to $372
Deutsche Bank Adjusts Price Target on Molina Healthcare to $391 From $353